344 related articles for article (PubMed ID: 17684018)
1. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression.
Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P
J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.
Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L
PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X; Fraser M; Qiu Q; Tsang BK
Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
[TBL] [Abstract][Full Text] [Related]
4. PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.
Zheng T; Meng X; Wang J; Chen X; Yin D; Liang Y; Song X; Pan S; Jiang H; Liu L
J Cell Biochem; 2010 Sep; 111(1):218-28. PubMed ID: 20506484
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.
Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA
Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance.
Singh M; Chaudhry P; Fabi F; Asselin E
BMC Cancer; 2013 May; 13():233. PubMed ID: 23663432
[TBL] [Abstract][Full Text] [Related]
7. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
8. Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.
Tu Y; Kim E; Gao Y; Rankin GO; Li B; Chen YC
Int J Oncol; 2016 Jun; 48(6):2657-65. PubMed ID: 27082635
[TBL] [Abstract][Full Text] [Related]
9. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644
[TBL] [Abstract][Full Text] [Related]
10. Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch.
Chen L; Li Q; Zheng Z; Xie J; Lin X; Jiang C; Xu H; Wu X; Wu J; Zhang H
Chem Biol Drug Des; 2019 Jul; 94(1):1368-1377. PubMed ID: 30873716
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression.
Selvendiran K; Kuppusamy ML; Bratasz A; Tong L; Rivera BK; Rink C; Sen CK; Kálai T; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2009 Jun; 329(3):959-66. PubMed ID: 19276401
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736
[TBL] [Abstract][Full Text] [Related]
13. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
Yang CH; Yue J; Sims M; Pfeffer LM
PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701
[TBL] [Abstract][Full Text] [Related]
14. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
[TBL] [Abstract][Full Text] [Related]
15. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
16. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
[TBL] [Abstract][Full Text] [Related]
17. Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells.
Tan X; Sidell N; Mancini A; Huang RP; Shenming Wang ; Horowitz IR; Liotta DC; Taylor RN; Wieser F
Reprod Sci; 2010 Oct; 17(10):931-40. PubMed ID: 20693500
[TBL] [Abstract][Full Text] [Related]
18. Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway.
Chen Q; Qin R; Fang Y; Li H
Cell Physiol Biochem; 2015; 36(3):956-65. PubMed ID: 26087719
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
20. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK.
Weir NM; Selvendiran K; Kutala VK; Tong L; Vishwanath S; Rajaram M; Tridandapani S; Anant S; Kuppusamy P
Cancer Biol Ther; 2007 Feb; 6(2):178-84. PubMed ID: 17218783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
